52 in 52: The Rivers Trial


    52 in 52: The Rivers Trial

    Title: “The 52 in 52 Review: Early goal-directed therapy in the treatment of severe sepsis and septic shock”

    Article Citation: Rivers E, Nguyen B, Havstad S, Ressler J, et al; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 8;345(19):1368-77. PMID: 11794169.

    What we already know about the topic: In patients with sepsis or septic shock, inflammatory changes causes circulatory abnormalities such as intravascular volume depletion, peripheral vasodilatation, myocardial depression, and increased metabolism which can then lead to an imbalance between systemic oxygen delivery and oxygen demand, resulting in global tissue hypoxia. Goal-directed therapy,  involving targeted adjustments of preload, afterload, and contractility to balance oxygen delivery with oxygen demand has been used for severe sepsis and septic shock in the ICU setting.

    Why this study is important: In this study, the authors evaluate the efficacy of early goal-directed therapy before admission to the intensive care unit, as defined by intensive monitoring of specific circulatory parameters with the aggressive management of 5 key parameters to specified targets to optimize oxygen delivery to tissues. This was one of the first studies to look at the effects of starting aggressive protocolized care early on in the ED treatment of septic patients.

    Brief overview of the study: The Rivers trial randomized 263 patients with severe sepsis or septic shock at a single urban Detroit ED to a protocol of early goal-directed therapy (EGDT) vs. standard therapy. In the EGDT arm, patients received an arterial line and a central line with continuous central venous oxygen saturation (ScvO2) monitoring. The EGDT group consisted of several sequential goals in the ER prior to ICU admission: CVP 8-12mmHg, achieved with fluid boluses, MAP >65mmHg, achieved with vasopressors if necessary, ScvO2 >70%, achieved with packed RBC transfusions and dobutamine if necessary, and UOP >0.5mL/kg/hr. The study found thatthe EGDT arm had a 16% absolute risk reduction in mortality.

    Limitations: There are several limitations in the Rivers trial, which subsequent studies such as ProCESS tried to address. First, ED staff taking care of patients could not be blinded due to the nature of the intervention. Secondly, the study has been criticized for a “Rivers effect” — that is, having a dedicated critical care trained doctor taking care of patients in the intervention arm. Based on the trial, it’s also difficult to determine what decreased mortality in patients and whether it was the entire EGDT protocol or a component. Finally, patients who received EGDT all received additional fluid (4.9 L vs. 3.5 L (P<0.001)) and additional blood product (0-6 hours: 64.1% vs. 18.5% (P<0.001)) compared to those in the standard treatment arm, which in the critically ill could be harmful due to fluid overload.

    Take home points: While the Rivers trial was groundbreaking in that it demonstrated adopting early goal directed care prior to the ICU decreased mortality in septic patients, the study had several limitations. Subsequent multi-center trials such as ProCESS, ProMISe and ARISE demonstrated that in patients who are recognized early on as having sepsis and treated with intravenous fluids and antibiotics, there was no significant benefit in EGDT.

    • Welcome! This is the website for the Mount Sinai Emergency Ultrasound Division. It serves as an information resource for residents, fellows, medical students and others seeking information about point-of-care ultrasound. There is a lot ofRead more

    • Slow down your tachycardia (but not really)

      You’re sitting in resus bemoaning the departure of your most beloved attending when suddenly a patient wheels in without warning. The patient looks relatively stable but the triage RN tells you her heart rate wasRead more

    • Otitis externa: use the ear wick!

      Acute otitis externa (AOE) is a common complaint seen in pediatric as well as adult emergency departments. AOE is typically not accompanied by acute otitis media, although concurrent cases are possible. Also called “swimmer’s ear”Read more

    • Reach for the COWS

      Your patient in intake is miserable. Doubled over, complaining of pain everywhere, sweating, ill-appearing but not unstable. He tells you that the last time he used heroin was two nights ago, and he is askingRead more

    • Tis the season, summer edition

      As the late spring rains have begun to fade and the temperature rises mercilessly into the 80s and beyond, summer is finally upon us. And with summer comes a host of diseases for the emergencyRead more

    • Meet the newest member of your team

      We have a new resource in the Sinai ED. Say hello to your friendly ED pharmacist. In the past several years, the ED pharmacy has been centralized in a non-ED location. We all know wellRead more

    • In the spirit of roasts and fire-breathing dragons

      You’re on a lovely amble through the backcountry when suddenly you see smoke rising nearby and catch a whiff of a familiar scent that throws you back to your med school OR days: burning flesh.Read more

    • E-point Septal Separation in the Patient with Congestive Heart Failure

      Perhaps never explained so clearly, Cisewki and Alerhand’s article on EPSS is a wonderful read. Bottom line to remember: EPSS > 7 mm was 87% sensitive and 75% specific at identifying reduced EF (<50%).  This isRead more

    • Lidocaine for cough?

      Whether it’s asthma, a U.R.I., or post nasal drip as the cause, cough is a common enough complaint encountered by emergency physicians everywhere. Of course you must always rule out the dangerous causes of coughRead more